Bleeding events within 24 h ( classified by an independent , blinded Adjudication Committee ) were reported in 17 ( 2.9 % ) sugammadex and 24 ( 4.1 % ) usual care patients ( relative risk [ 95 % CI ] , 0.70 [ 0.38 to 1.29 ] ) .